基因技术公司和从英克隆公司的老板都随随便便地就拒绝了收购的出价。
The bosses of both Genentech and ImClone have unceremoniously rejected the offers made by their partners.
而英克隆系统公司的抗癌药物Erbitux引起警告是由于百分之三左右的患者中存在严重并且有时甚至致命的反应。
And ImClone Systems Inc's cancer drug Erbitux carries a warning due to serious and sometimes fatal reactions in about 3 percent of patients.
而英克隆系统公司的抗癌药物Erbitux引起警告是由于百分之三左右的患者中存在严重并且有时甚至致命的反应。
And ImClone Systems Inc's cancer drug Erbitux carries a warning due to serious and sometimes fatal reactions in about 3 percent of patients.
应用推荐